Oruka Therapeutics earnings were -$116.3M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest ORKA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$31.8M, up 7.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ORKA reported annual earnings of -$105.4M, with 25.9% growth. The next ORKA earnings date is Aug 10, 2026.
What were Oruka Therapeutics's earnings last quarter?
Oruka Therapeutics (NASDAQ: ORKA) reported Q1 2026 earnings per share (EPS) of -$0.48, up 20% year over year. Total ORKA earnings for the quarter were -$31.82 million. In the same quarter last year, Oruka Therapeutics's earnings per share (EPS) was -$0.40.
The next ORKA earnings call is Invalid Date. Add ORKA to your watchlist to be reminded of Oruka Therapeutics's next earnings date.
Is Oruka Therapeutics profitable or losing money?
As of the last Oruka Therapeutics earnings report, Oruka Therapeutics is currently losing money. Oruka Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$116.25 million, a 19.06% increase year over year.
What was ORKA's earnings growth in the past year?
As of Oruka Therapeutics's earnings date in Q2 2026, Oruka Therapeutics's earnings has grown year over year. ORKA earnings in the past year totalled -$116.25 million.
What are Oruka Therapeutics's earnings expectations?
The current EPS estimate for Oruka Therapeutics's earnings report in Invalid Date is -$0.49.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.